Safety and Efficacy Results of a Phase II Randomized, Placebo-Controlled, Dose-Ranging Study of Elnd005 (Scyllo-Inositol) in Mild-To-Moderate Alzheimer's Disease
Alzheimer's and Dementia - United States
doi 10.1016/j.jalz.2011.05.1371
Full Text
Open PDFAbstract
Available in full text
Categories
Date
July 1, 2011
Authors
Publisher
Wiley